MIR-519d-mediated downregulation of STAT3 suppresses breast cancer progression

Oncology Reports

Volumn 34, Issue 4, 2015, Pages 2188-2194

  Deng, Xin ^a   Zhao, Yi ^a   Wang, Baosheng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Breast cancer; Metastasis; MIR 519d; STAT3

Indexed keywords

MICRORNA; MICRORNA 519D; STAT3 PROTEIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MIRN519 MICRORNA, HUMAN; STAT3 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER INHIBITION; CANCER TISSUE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAT3 GENE; WESTERN BLOTTING; 3' UNTRANSLATED REGION; ANIMAL; BREAST TUMOR; CANCER TRANSPLANTATION; CELL MOTION; DISEASE COURSE; GENETICS; MCF 7 CELL LINE; METABOLISM; METASTASIS; PATHOLOGY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; MICE; MICRORNAS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; STAT3 TRANSCRIPTION FACTOR;

EID: 84939161385     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.4160     Document Type: Article

References (22)

1. Vislovukh A, Vargas TR, Polesskaya A and Groisman I: Role of 3'-untranslated region translational control in cancer development, diagnostics and treatment. World J Biol Chem 5: 40-57, 2014.
2. van Rooij E and Kauppinen S: Development of microRNA therapeutics is coming of age. EMBO Mol Med 6: 851-864, 2014.
3. Zhu J, Zheng Z, Wang J, Sun J, Wang P, Cheng X, Fu L, Zhang L, Wang Z and Li Z: Different miRNA expression profiles between human breast cancer tumors and serum. Front Genet 5: 149, 2014.
4. Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin 64: 9-29, 2014.
5. Corcoran C, Friel AM, Duffy MJ, Crown J and O'Driscoll L: Intracellular and extracellular microRNAs in breast cancer. Clin Chem 57: 18-32, 2011.
6. Melo SA and Esteller M: Dysregulation of microRNAs in cancer: Playing with fire. FEBS Lett 585: 2087-2099, 2011.
7. Greene SB, Herschkowitz JI and Rosen JM: Small players with big roles: microRNAs as targets to inhibit breast cancer progression. Curr Drug Targets 11: 1059-1073, 2010.
8. Le Quesne J and Caldas C: Micro-RNAs and breast cancer. Mol Oncol 4: 230-241, 2010.
9. Tsai CH, Tsai HC, Huang HN, Hung CH, Hsu CJ, Fong YC, Hsu HC, Huang YL and Tang CH: Resistin promotes tumor metastasis by down-regulation of miR-519d through the AMPK/p38 signaling pathway in human chondrosarcoma cells. Oncotarget 6: 258-270, 2015.
10. Tsai HC, Su HL, Huang CY, Fong YC, Hsu CJ and Tang CH: CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d. Oncotarget 5: 3800-3812, 2014.
11. Pang Y, Mao H, Shen L, Zhao Z, Liu R and Liu P: MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP. Onco Targets Ther 7: 587-597, 2014.
12. Fornari F, Milazzo M, Chieco P, Negrini M, Marasco E, Capranico G, Mantovani V, Marinello J, Sabbioni S, Callegari E, et al: In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2. J Pathol 227: 275-285, 2012.
13. Hou YY, Cao WW, Li L, Li SP, Liu T, Wan HY, Liu M, Li X and Tang H: MicroRNA-519d targets MKi67 and suppresses cell growth in the hepatocellular carcinoma cell line QGY-7703. Cancer Lett 307: 182-190, 2011.
14. Haura EB, Turkson J and Jove R: Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer. Nat Clin Pract Oncol 2: 315-324, 2005.
15. Walker SR, Xiang M and Frank DA: Distinct roles of STAT3 and STAT5 in the pathogenesis and targeted therapy of breast cancer. Mol Cell Endocrinol 382: 616-621, 2014.
16. Clevenger CV: Roles and regulation of stat family transcription factors in human breast cancer. Am J Pathol 165: 1449-1460, 2004.
17. Haghikia A, Hoch M, Stapel B and Hilfiker-Kleiner D: STAT3 regulation of and by microRNAs in development and disease. JAK-STAT 1: 143-150, 2012.
18. Zhao G, Zhang JG, Shi Y, Qin Q, Liu Y, Wang B, Tian K, Deng SC, Li X, Zhu S, et al: Correction: miR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3. PLoS One 8: e73803, 2013.
19. Zhang X, Tang J, Zhi X, Xie K, Wang W, Li Z, Zhu Y, Yang L, Xu H and Xu Z: miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in gastric cancer. Oncotarget 6: 1605-1617, 2015.
20. Xiao Y, Wang J, Yan W, Zhou Y, Chen Y, Zhou K, Wen J, Wang Y and Cai W: Dysregulated miR-124 and miR-200 expression contribute to cholangiocyte proliferation in the cholestatic liver by targeting IL-6/STAT3 signalling. J Hepatol 62: 889-896, 2015.
21. Jiang J, Li Z, Yu C, Chen M, Tian S and Sun C: MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer. Cancer Lett 356: 962-970, 2015.
22. Zhang H, Cai K, Wang J, Wang X, Cheng K, Shi F, Jiang L, Zhang Y and Dou J: MiR-7, inhibited indirectly by lincRNA HOTAIR, directly inhibits SETDB1 and reverses the EMT of breast cancer stem cells by downregulating the STAT3 pathway. Stem Cells 32: 2858-2868, 2014.